Patents by Inventor Marta Carrascal Riera

Marta Carrascal Riera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolotriazinone derivatives as PI3K inhibitors
    Patent number: 9388189
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of Formula (I) are disclosed; as well as process for theft preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: July 12, 2016
    Assignee: Almirall, S.A.
    Inventors: Montserrat Erra Sola, Marta Carrascal Riera, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Francisco Javier Bernal Anchuela, Lluis Miquel Pages Santacana, Marta Mir Cepeda, Gaspar Casals Coll, Maria Begoña Hernandez Olasagarre
  • Pyrrolotriazinone derivatives as inhibitors P13K
    Patent number: 9340547
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: May 17, 2016
    Assignee: Almirall, S.A.
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Taltavull Moll, Montserrat Erra Sola
  • PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS
    Publication number: 20150291595
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of Formula (I) are disclosed; as well as process for theft preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: October 15, 2013
    Publication date: October 15, 2015
    Inventors: Montserrat Erra Sola, Marta Carrascal Riera, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Francisco Javier Bernal Anchuela, Lluis Miquel Pages Santacana, Marta Mir Cepeda, Gaspar Casals Coll, Maria Begoña Hernandez Olasagarre
  • PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS
    Publication number: 20150099752
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: April 26, 2012
    Publication date: April 9, 2015
    Applicant: ALMIRALL, SA
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Tal Tavul Moll, Montserat Eraa Sola
  • PYRROLOTRIAZINONE DERIVATIVES AS P13K INHIBITORS
    Publication number: 20140163033
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: April 26, 2012
    Publication date: June 12, 2014
    Applicant: ALMIRALL, SA
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Tal Tavul Moll, Montserat Eraa Sola
  • 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE
    Publication number: 20110311485
    Abstract: The present disclosure relates to 1, 2, 4 oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors.
    Type: Application
    Filed: December 15, 2009
    Publication date: December 22, 2011
    Applicant: ALMIRALL S.A.
    Inventors: Victor Giulio Matassa, Nuria Aguilar Izquierdo, Marta Mir Cepeda, Marta Carrascal Riera, Silvia Fonquerna Pou, Aranzazu Cardus Figueras, Julio Cesar Castro Palomino Laria, Montserrat Erra Sola
  • OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR ANTAGONISTS
    Publication number: 20110274657
    Abstract: The present disclosure relates to oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptor.
    Type: Application
    Filed: January 14, 2010
    Publication date: November 10, 2011
    Inventors: Nuria Aguilar Izquierdo, Marta Carrascal Riera, Julio Cesar Castro Palomino Laria, Montserrat Erra Sola
  • NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES
    Publication number: 20100204241
    Abstract: Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4: wherein R1, R2 and R4 are organic radicals, R3 is a cyclic group, and R5 is an ester or an aryl or heteroaryl group.
    Type: Application
    Filed: October 8, 2008
    Publication date: August 12, 2010
    Inventors: Vittorio Dal Piaz, Nuria Aguilar Izquierdo, Maria Antonia Buil Albero, Marta Carrascal Riera, Jordi Gracia Ferrer, Maria Paola Giovannoni, Claudia Vergelli
  • NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES
    Publication number: 20090111819
    Abstract: Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4: wherein R1, R2 and R4 are organic radicals, R3 is a cyclic group, and R5 is an ester or an aryl or heteroaryl group.
    Type: Application
    Filed: October 8, 2008
    Publication date: April 30, 2009
    Inventors: Vittorio Dal Piaz, Nuria Aguilar Izquierdo, Maria Antonia Buil Albero, Marta Carrascal Riera, Jordi Gracia Ferrer, Maria Paola Giovannoni, Claudia Vergelli
  • Pyridazin-3(2H)-one derivatives
    Patent number: 7491722
    Abstract: Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4. R1, R2 and R4 are organic radicals, R3 is a cyclic group, and R5 is an ester or an aryl or heteroaryl group.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: February 17, 2009
    Assignee: Laboratorios Almirall S.A.
    Inventors: Vittorio Dal Piaz, Nuria Aguilar Izquierdo, Maria Antonia Buil Albero, Marta Carrascal Riera, Jordi Gracia Ferrer, Maria Paola Giovannoni, Claudia Vergelli
  • Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors
    Publication number: 20090029996
    Abstract: The invention relates to new therapeutically useful pyridazin-3(2H)-one derivatives, to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent and selective inhibitors of phosphodiesterase 4 (PDE4) and are thus useful in the treatment, prevention and suppression of related pathological conditions, diseases and disorders, in particular asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, topic dermatitis, psoriasis or irritable bowel disease.
    Type: Application
    Filed: June 21, 2005
    Publication date: January 29, 2009
    Inventors: Nuria Aguilar Izquierdo, Marta Carrascal Riera, Vittorio Dal Piaz, Jordi Gracia Ferrer, Wenceslao Lumeras Amador, Maria Del Carmen Masdeu Margalef, Graham Warrellow
  • New pyridazin-3(2h)-one derivatives
    Publication number: 20060173008
    Abstract: Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4. R1, R2 and R4 are organic radicals, R3 is a cyclic group, and R5 is an ester or an aryl or heteroaryl group.
    Type: Application
    Filed: December 22, 2003
    Publication date: August 3, 2006
    Inventors: Vittorio Dal Piaz, Nuria Aguilar Izquierdo, Maria Buil Albero, Marta Carrascal Riera, Jordi Gracia Ferrer, Maria Giovannoni, Claudia Vergelli